In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immimohistological evidence-Reference-Cited by-同舟云学术

In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immimohistological evidence

Published:1992-09 Issue:1 Volume:82 Page:38-45
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Falini B.,Flenghi L.,Fedeli L.,Broe M. K.,Bonino C.,Stein H.,Düurkop H.,Bigerna B.,Barbabietola G.,Venturi S.,Aversa F.,Pizzolo G.,Bartoli A.,Pileri S.,Sabattini E.,and R. Palumbo,Martelli M. F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1992.tb04591.x/fullpdf

Reference33 articles.

1. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon

2. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CD 30 in Lymphoid Neoplasms;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience;Toxins;2022-08-18

3. Targeting CD30 in Patients with Hodgkin Lymphoma;Hodgkin Lymphoma;2020

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma

;Blood and Lymphatic Cancer: Targets and Therapy;2019-12

5. Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment;Leukemia & Lymphoma;2019-07-14